divyajivan

Qualifications

Academic Qualifications

M.B.B.S.

B.J. Medical College, Gujarat University
-2000
2000

M.D. (Internal Medicibe)

B.J. Medical College, Gujarat University
-2004
2004

PGP In Management

IMT Ghaziabad
-2021 *pursuing
2021

Certifications

Certifications

Fellow in Cardiology

U.N. Mehta Cardiology Institute, Civil Hospital, Ahmedabad

-2004

Associate fellow in industrial health

Mahatma Gandhi Labor Institute
-2007

Exec. management development program

Pricing for Profit – IIM Ahmedabad
-2018

Accounting fundamentals

Corporate Finance Institute(CFI)
-2021

Current position

Current position

  • 1
    CEO – BAPS Pramukh Swami Hospital, Surat, Gujarat
  • 2
    Head – Department of Clinical Research – BAPS Pramukh Swami Hospital
  • 3
    PG Teacher (DNB Medicine) & Head of Department – General Medicine
  • 4
    Innovator & Promotor – Divyajivan Healthcare Pvt Ltd.
  • 5
    NABH ASSESSOR for Clinical Trials Ethics Commititttee
  • 6
    DNB (General Medicine) – PG Examiner
  • 7
    Secretary – Gujarat Chapter – Association of National Boared Accredited Institutions

Experience

Experience

  • 1
    Physician – Clinical Experience – 18 years
  • 2
    Chief Executive Officer – 9 years
  • 3
    Head Clinical Research – and principal investigator – 9 years
  • 4
    Academics – teaching for DNB and IDCCM courses – 6 years
  • 5
    Assessor for NABH Ethics Committee – 4 years

study details

List of clinical research experience

  • Genova Biopharmaceutical Ltd-GBL/HGCO19/2021/01 (mRNA Novel corona Vaccine) (Phase II/III)
  • Novel Corona Virus 2019- nCov vaccine (ZyCov-D–2-dose Regimen)(Phase III)
  • Novel Corona Virus – Ad26.COV2.S Vaccine-(J & J) (Phase II/III)
  • Ensovibep (MP0420) in Adult Symptomatic COVID-19-Mild (EMPATHY-Novartis) (Phase II/III)
  • Novel Corona Virus 2019 Vaccine- CORBEVX-(Biological-E) (Phase III)
  • Novel Corona Virus 2019 – nCov vaccine (ZyCov-D) (Phase |||) (Zydus)
  • Evaluation of 2-Deoxy-D-Glucose In Covid-19 Rx (GENIUS Study) (DRDO/DRL/IQVIA)
  • SARS-Cov-2-Vaccine-Gam-COVID-Vac (SPUTNIK V) (JSS/DRL)
  • Pegylated IFN alfa 2b in SARS – Cov 2 (Covid 19) treatment (Phase |||) (Zydus)
  • Novel Corona Virus 2019 – nCov vaccine (ZyCov-D) (Phase ||) (Zydus)
  • Pegylated IFN alfa 2b in SARS – Cov 2 (Covid 19) treatment (Phase ||) (Zydus)
  • UIcerative Colitis (Phase ||) (KlinEra/Gilead science)
  • CKD Induce Anemia (Non Dialysis) (Desidustat) (Phase |||) (Zydus)
  • CV Risk Assessment In Type || DM with High TG (PemaFibrate) (Phase |||) (IQVIA/KOWA)
  • Influenza A-Pimodivir (OPD) (Phase |||) (Janssen J & J / IQVIA)
  • Influenza A-Pimodivir (IPD) (Phase |||) (Janssen J & J / IQVIA)
  • Metabolic syndrome-TRC150094 (Phase III) (Torrent /IQVIA)
  • Statin Intolerance- Bempedoic acid (Phase III) (Esperion/ IQVIA
  • NAFLD (Saroglitazar) (Phase III) (Zydus)
  • Type Il DM (Repa+Vogli) (Phase III) (Torrent)
  • NASH (Saroglitazar) (Phase III) (Zydus)
  • Urinary Tract Infection (Observational)
  • CKD Induce Anemia (Desidustat) (Phase II) (zydus)
  • Metabolic syndrome (Phase III) (Torrent / SIRO)
  • Type II DM ( Exenatide )(Phase II)(SUN Pharma)
  • Metabolic syndrome (Phase III) (Torrent / SIRO)
  • Major Cardiovascular Events-PCSK-9 Inhibitor (Phase III) (Pfizer/ICON)

research publications

research publications

  • bullets
    A prospective, multi-center, double blind, randomized trial of saroglitazar 4 mg compared to placebo in patients eith non-alcoholic steatohepatitis – published in Journal of APASL (Asian Pacific Asociation for the Study of the Liver)
  • bullets
    Outcomes of Desidustat treatment in a people with Anemia and Chronic Kidney Disease: A phase 2 study – published in American Journal of Nephrology
  • bullets
    Efficacy and Safety of pegylated interferon alfa-2b in moderate COVID-19: A phase ||, randomized controlled open-label study – published in international Journal of Infectious Disease
  • bullets
    Efficacy Safety Immunogenicity of the DNA SARS-CoV-2 Vaccine ( ZyCov – D ): Phase III , Randomized Double – Blind Placebo-Controlled Study in India

Life member

Professional memberships

Life member

Life member

Life member

Life member

Life member

once during plan

basic medical instruments

digital BP instrument

pulse oxymetery

spiro meter

nebilizer machine

glucometer with stripes

first aid kit

Actual device might be different in design and size. This images are just for graphical representation